Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug:121:203-210.
doi: 10.1016/j.ijid.2022.05.005. Epub 2022 May 6.

COVID-19-Associated Mucormycosis: An Opportunistic Fungal Infection. A Case Series and Review

Affiliations
Review

COVID-19-Associated Mucormycosis: An Opportunistic Fungal Infection. A Case Series and Review

Asma Al Balushi et al. Int J Infect Dis. 2022 Aug.

Abstract

Background: A surge in COVID-19-associated mucormycosis cases has been observed during the second wave of COVID-19 in summer of 2021. Most cases were reported from India. The Delta variant (B.1.617.2) was the most common variant circulating at that time. Mucormycosis is an opportunistic angioinvasive fungal infection with high morbidity and mortality.

Methods: We present 10 cases of COVID-19-associated rhino-orbital and rhino-orbital-cerebral mucormycosis managed in a secondary hospital in Oman.

Results: The median time for developing mucormycosis was two weeks after COVID-19 diagnosis. All patients were newly diagnosed or already known to have poorly controlled diabetes mellitus. Five patients received corticosteroid therapy for COVID-19. Three patients had severe COVID-19 and died of severe acute respiratory distress syndrome and septic shock. Another three patients died of advanced mucormycosis and cerebral involvement. Despite aggressive medical and surgical intervention, the mortality rate was 60% (6/10).

Conclusion: Mucormycosis is an aggressive opportunistic infection with high morbidity and mortality that requires prompt recognition and urgent intervention. Uncontrolled blood sugar, the use of corticosteroids, and immune dysfunction due to COVID-19 are all important risk factors for development of mucormycosis. Worse outcomes are associated with poor glycemic control despite aggressive medical and surgical interventions.

Keywords: COVID-19 associated mucormycosis; COVID-19 variants; Invasive mold infections; Mucorales; Rhino-orbital-cerebral mucormycosis; Rhizopus oryzae.

PubMed Disclaimer

Conflict of interest statement

Declarations of competing interest The authors have no competing interests to declare.

Figures

Figure 1
Figure 1
A. Hard palate grossly involved with the disease. Black eschar is visible. B. Pre-operative endoscopic view of right-side posterior nasal cavity. C. Fungal hyphae growth in post-operative nasal cavity. D. Maxillary sinus mucosa appears pale and sloughy. E. Imprint smear showing broad, ribbon-like and twisted, non-septate fungal hyphae displaying right-angled branching (Hematoxylin and Eosin 200X). F. Histopathological section showing perineural infiltration by broad wide-angled branching fungal hyphae (Hematoxylin and Eosin 400X). G. Coronal computed tomography (CT) image shows unilateral mucosal thickening of left maxillary and left ethmoid sinuses. H. Axial CT image shows unilateral left nasal cavity and maxillary sinus mucosal thickening. There is soft tissue infiltration of left anterior periantral fat. I. Dilated right superior ophthalmic vein. J. Axial CT head shows right sided fronto-parietal ischemic infarct.

Similar articles

Cited by

References

    1. Al Shahawey MG, El-Housseiny GS, Elsayed NS, Alshahrani MY, El Wakeel LM, Aboshanab KM. New insights on mucormycosis and its association with the COVID-19 pandemic. Future Sci OA. 2022;8:FSO772. - PMC - PubMed
    1. Cornely OA, Alastruey-Izquierdo A, Arenz D, Chen SCA, Dannaoui E, Hochhegger B, et al. Global guideline for the diagnosis and management of mucormycosis: an initiative for the European Confederation of medical mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect Dis. 2019;19:E405–E421. - PMC - PubMed
    1. Garg D, Muthu V, Sehgal IS, Ramachandran R, Kaur H, Bhalla A, et al. Coronavirus disease (COVID-19) associated mucormycosis (CAM): case report and systematic review of literature. Mycopathologia. 2021;186:289–298. - PMC - PubMed
    1. Goddanti N, Reddy YM, Kumar MK, Rajesh M. Role of COVID-19 inflammatory markers in rhino-orbito-cerebral mucormycosis: A case study in predisposed patients at a designated nodal centre. Indian J Otolaryngol Head Neck Surg. 2021;(Nov 13):1–7. - PMC - PubMed
    1. Gupta R, Kesavadev J, Krishnan G, Agarwal S, Saboo B, Shah M, et al. COVID-19 associated mucormycosis: A descriptive Multisite Study from India. Diabetes Metab Syndrome. 2021;15 - PMC - PubMed

MeSH terms

Supplementary concepts